Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain.
Liu C, Miao R, Raza F, Qian H, Tian X.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2022.114893 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för amg-517. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
10 träffarStructural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Das B, Baidya ATK, Mathew AT, Yadav AK, Kumar R.
Bioorg Med Chem · review; journal article · DOI 10.1016/j.bmc.2022.116614Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.
Subbaiah MAM, Meanwell NA.
J Med Chem · review; journal article · DOI 10.1021/acs.jmedchem.1c01215Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
Blum CA, Caldwell T, Zheng X, Bakthavatchalam R, Capitosti S, Brielmann H, De Lombaert S, Kershaw MT, Matson D, Krause JE, Cortright D, Crandall M, Martin WJ, Murphy BA, Boyce S, Jones AB, Mason G, Rycroft W, Perrett H, Conley R, Burnaby-Davies N, Chenard BL, Hodgetts KJ.
J Med Chem · journal article · DOI 10.1021/jm100051gSubstituted aryl pyrimidines as potent and soluble TRPV1 antagonists.
Stec MM, Bo Y, Chakrabarti PP, Liao L, Ncube M, Tamayo N, Tamir R, Gavva NR, Treanor JJ, Norman MH.
Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2008.07.112Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
Tamayo N, Liao H, Stec MM, Wang X, Chakrabarti P, Retz D, Doherty EM, Surapaneni S, Tamir R, Bannon AW, Gavva NR, Norman MH.
J Med Chem · journal article · DOI 10.1021/jm70146384-Aminopyrimidine tetrahydronaphthols: a series of novel vanilloid receptor-1 antagonists with improved solubility properties.
Doherty EM, Retz D, Gavva NR, Tamir R, Treanor JJ, Norman MH.
Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2008.02.022Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility.
Wang X, Chakrabarti PP, Ognyanov VI, Pettus LH, Tamir R, Tan H, Tang P, Treanor JJ, Gavva NR, Norman MH.
Bioorg Med Chem Lett · comparative study; journal article · DOI 10.1016/j.bmcl.2007.09.080Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
Doherty EM, Fotsch C, Bannon AW, Bo Y, Chen N, Dominguez C, Falsey J, Gavva NR, Katon J, Nixey T, Ognyanov VI, Pettus L, Rzasa RM, Stec M, Surapaneni S, Tamir R, Zhu J, Treanor JJ, Norman MH.
J Med Chem · journal article · DOI 10.1021/jm070190pNovel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties.
Wang HL, Katon J, Balan C, Bannon AW, Bernard C, Doherty EM, Dominguez C, Gavva NR, Gore V, Ma V, Nishimura N, Surapaneni S, Tang P, Tamir R, Thiel O, Treanor JJ, Norman MH.
J Med Chem · journal article · DOI 10.1021/jm070191h